- Home
- ATHA vs SANW Comparison
ATHA vs SANW Comparison
Compare ATHA & SANW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATHA
- SANW
- Stock Information
- Founded
- ATHA 2011
- SANW 1980
- Country
- ATHA United States
- SANW United States
- Employees
- ATHA N/A
- SANW N/A
- Industry
- ATHA Medicinal Chemicals and Botanical Products
- SANW Farming/Seeds/Milling
- Sector
- ATHA Health Care
- SANW Consumer Staples
- Exchange
- ATHA Nasdaq
- SANW Nasdaq
- Market Cap
- ATHA 21.0M
- SANW 18.8M
- IPO Year
- ATHA 2020
- SANW 2010
- Fundamental
- Price
- ATHA $0.27
- SANW $7.05
- Analyst Decision
- ATHA Buy
- SANW Strong Buy
- Analyst Count
- ATHA 4
- SANW 1
- Target Price
- ATHA $11.25
- SANW $35.00
- AVG Volume (30 Days)
- ATHA 209.7K
- SANW 6.1K
- Earning Date
- ATHA 05-14-2025
- SANW 05-13-2025
- Dividend Yield
- ATHA N/A
- SANW N/A
- EPS Growth
- ATHA N/A
- SANW N/A
- EPS
- ATHA N/A
- SANW N/A
- Revenue
- ATHA N/A
- SANW $54,809,365.00
- Revenue This Year
- ATHA N/A
- SANW N/A
- Revenue Next Year
- ATHA N/A
- SANW $14.25
- P/E Ratio
- ATHA N/A
- SANW N/A
- Revenue Growth
- ATHA N/A
- SANW N/A
- 52 Week Low
- ATHA $0.25
- SANW $2.10
- 52 Week High
- ATHA $3.67
- SANW $11.60
- Technical
- Relative Strength Index (RSI)
- ATHA 29.05
- SANW 40.48
- Support Level
- ATHA $0.25
- SANW $6.73
- Resistance Level
- ATHA $0.31
- SANW $7.24
- Average True Range (ATR)
- ATHA 0.03
- SANW 0.60
- MACD
- ATHA -0.00
- SANW -0.05
- Stochastic Oscillator
- ATHA 12.38
- SANW 18.90
About ATHA Athira Pharma Inc.
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) a subcutaneously administered, small molecule positive modulator of the HGF/MET system for CNS disorders, ATH-1020 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system. ATH-1105 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system, and several other compounds in preclinical discovery and development for neurodegenerative diseases, including ATH-1018 and ATH-1019.
About SANW S&W Seed Company (NV)
S&W Seed Co is a multi-crop, middle-market agricultural company. It is engaged in the breeding, production, and sale of alfalfa seed and sorghum seed. It also has a growing commercial market presence in sunflower and maintains an active stevia development program. The company's seed platform develops and supplies germplasm designed to produce higher yields for farmers globally. Its geographical segments include the United States, Australia, Saudi Arabia, Mexico, South Africa, and other countries. Maximum of revenue is earned from USA following Australia second and Mexico third.